Part Number
Part Number:
NSN:
NIIN:
Item Name:
CYCLOPHOSPHAMIDE FOR INJECTION , U
Definition:
CAGE Information
| Code | Company |
|---|---|
| 0NUD3 | BRISTOL-MYERS SQUIBB COMPANY DBA BRI |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.000 GRAMS OF ACTIVE INGREDIENT |
| CBBL | FEATURES PROVIDED | STERILE |
| AJCN | PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| AGXW | PHYSICAL FORM | FREEZE-DRIED POWDER |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CYCLOPHOSPHAMIDE FOR INJECTION USP 2GM VIAL FREEZE DRIED POWDER 6S |
| CQPQ | WARNING AND CAUTION STATEMENTS | CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 6 |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT |